CHIPPS研究:养老院独立药师处方干预的过程评估方案
CHIPPS试验是一项正在进行的整群随机对照试验,评估独立处方药师负责养老院药物管理的有效性与成本效果。本方案为其混合方法过程评估,依据MRC指南,旨在描述干预实施质量与变异、探索各成分对主要结局的影响及作用机制,并从多视角评估感知有效性、覆盖面和常规化程度,以解释主试验结果并指导后续实施。
要点
- 过程评估采用混合方法,涵盖问卷调查、记录审查和访谈。
- 评估聚焦干预实施的质量、数量、适应性及跨机构与时间变异。
- 旨在解释主试验结果并识别实施促进因素、障碍与未来调整。
核心结论
- 该过程评估将为解释CHIPPS主试验结果及服务后续实施提供依据。
研究设计与样本
- 整群随机对照试验的混合方法过程评估,遵循MRC过程评估指南。
- 采用定量(调查、记录审查)与定性(访谈)方法收集数据。
主要发现
- 评估将描述干预实施的质量、数量、适应性及跨机构与时间变异。
- 将探索各干预成分对主要结局的影响及作用机制。
- 将从全科医生、养老院、药师独立处方者及居民/亲属视角评估感知有效性。
- 将评估干预在医护人员及相关实践人员中的常规化程度。
临床怎么用
- 系统全面评估有助于理解服务实施情况与试验结果,识别有效要素及促进与阻碍因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prescribing, monitoring and administration of medicines in care homes could be improved. A cluster randomised controlled trial (RCT) is ongoing to evaluate the effectiveness of an independent prescribing pharmacist assuming responsibility for medicines management in care homes compared to usual care. AIMS AND OBJECTIVES: To conduct a mixed-methods process evaluation of the RCT, in line with Medical Research Council (MRC) process evaluation guidance, to inform interpretation of main trial findings and if the service is found to be effective and efficient, to inform subsequent implementation. OBJECTIVES: 1. To describe the intervention as delivered in terms of quality, quantity, adaptations and variations across triads and time. 2. To explore the effects of individual intervention components on the primary outcomes. 3. To investigate the mechanisms of impact. 4. To describe the perceived effectiveness of relevant intervention components [including pharmacist independent prescriber (PIP) training and care home staff training] from participant [general practitioner (GP), care home, PIP and resident/relative] perspectives. 5. To describe the characteristics of GP, care home, PIP and resident participants to assess reach. 6. To estimate the extent to which intervention delivery is normalised among the intervention healthcare professionals and related practice staff. METHODS: A mix of quantitative (surveys, record reviews) and qualitative (interviews) approaches will be used to collect data on the extent of the delivery of detailed tasks required to implement the new service, to collect data to confirm the mechanism of impact as hypothesised in the logic model, to collect explanatory process and final outcome data, and data on contextual factors which could have facilitated or hindered effective and efficient delivery of the service. DISCUSSION: Recruitment is ongoing and the trial should complete in early 2020. The systematic and comprehensive approach that is being adopted will ensure data is captured on all aspects of the study, and allow a full understanding of the implementation of the service and the RCT findings. With so many interrelated factors involved it is important that a process evaluation is undertaken to enable us to identify which elements of the service were deemed to be effective, explain any differences seen, and identify enablers, barriers and future adaptions. TRIAL REGISTRATION: ISRCTN17847169. Date registered: 15 December 2017.
引用
- Bond CM, Holland R, Alldred DP, et al. Protocol for the process evaluation of a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS study. Trials. 2020. PMID: 32471514. doi:10.1186/s13063-020-04264-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。